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Abstract
Background: There is wide-spread human exposure to bisphenol A (BPA), a ubiquitous estrogenic endocrine disruptor that
has been implicated as having potentially harmful effects on human heart health. Higher urine BPA concentrations have
been shown to be associated with cardiovascular diseases in humans. However, neither the nature nor the mechanism(s) of
BPA action on the heart are understood.
Methodology/Principal Findings: The rapid (,7 min) effects of BPA and 17b-estradiol (E2) in the heart and ventricular
myocytes from rodents were investigated in the present study. In isolated ventricular myocytes from young adult females,
but not males, physiological concentrations of BPA or E2 (10
29 M) rapidly induced arrhythmogenic triggered activities. The
effects of BPA were particularly pronounced when combined with estradiol. Under conditions of catecholamine stimulation,
E2 and BPA promoted ventricular arrhythmias in female, but not male, hearts. The cellular mechanism of the female-specific
pro-arrhythmic effects of BPA and E2 were investigated. Exposure to E2 and/or BPA rapidly altered myocyte Ca
2+ handling;
in particular, estrogens markedly increased sarcoplasmic reticulum (SR) Ca
2+ leak, and increased SR Ca
2+ load. Ryanodine
(10
27 M) inhibition of SR Ca
2+ leak suppressed estrogen-induced triggered activities. The rapid response of female myocytes
to estrogens was abolished in an estrogen receptor (ER) b knockout mouse model.
Conclusions/Significance: Physiologically-relevant concentrations of BPA and E2 promote arrhythmias in a female-specific
manner in rat hearts; the pro-arrhythmic actions of estrogens are mediated by ERb-signaling through alterations of myocyte
Ca
2+ handling, particularly increases in SR Ca
2+ leak. Our study provides the first experimental evidence suggesting that
exposure to estrogenic endocrine disrupting chemicals and the unique sensitivity of female hearts to estrogens may play a
role in arrhythmogenesis in the female heart.
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Introduction
Estrogenic endocrine disrupting chemicals (EDCs) are a
structurally diverse group of compounds that mimic, or antagonize
the effects of endogenous estrogens. A particularly significant
example of estrogenic EDCs to human health is the nearly
ubiquitous xenoestrogen bisphenol A (BPA). BPA is structurally
similar to the potent non-steroidal synthetic estrogen diethylstilbes-
trol. As one of the highest produced synthetic chemicals worldwide,
BPA is used extensively in the production of polycarbonate plastic
and epoxy resins that are found in a wide range of consumer
products such as food containers, food cans, water bottles, baby
bottles, dental sealants and water pipes. Bioactive BPA is released
from epoxy resins and polycarbonate food and beverage containers,
especially after exposure to elevated temperatures [1]. Consequent-
ly, there is broad human exposure to BPA [2]. It has been shown
that BPA is present at detectable levels in urine, which are
considered the appropriate body fluid for assessing BPA exposure,
of over 90% of individuals examined in the US population[2,3,4,5].
There is significant public, scientific and regulatory interest in
elucidating the impact of BPA exposure on human health.
Experimental evidence has demonstrated potential links between
BPA exposure and cancer, obesity, diabetes, and disorders of the
reproductive, neuroendocrine and immune systems in a variety of
cellular and animal models [6]. The dose range in the animal
studies demonstrating BPA-induced pathogenesis correlates with
the BPA concentrations for human exposure [2,7,8,9]. However,
despite the increasing recognition that the endocrine disrupting
activities of BPA may have adverse health impact, the effect(s) of
environmentally-relevant concentrations of BPA remains contro-
versial, and the impact of BPA in the heart is unknown.
Retrospective epidemiologic investigation of health effects associ-
ated with BPA exposure suggests that higher urine BPA
concentrations are associated with cardiovascular disease and
other diseases in the US population [10], highlighting the
potentially important influence of BPA exposure on cardiac
pathophysiology.
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25455Cardiovascular disease is a leading cause of mortality in
developed countries, for both men and women. Estrogen has
strong influences on the sexually-dimorphic baseline physiology of
the heart, and on myocardial responses associated with various
cardiac pathophysiological conditions including hypertrophy,
failure, ischemic injury, and arrhythmias [11,12,13,14]. The
regulatory mechanisms of estrogen’s actions on the myocardium
are complex. In addition to regulation of gene expression through
nuclear hormone receptor activity, estradiol and BPA can elicit
cell-specific responses through activation of intracellular signaling
pathways associated with membrane-localized estrogen receptors
[12,13,15]. These effects occur rapidly within seconds to minutes
and are independent from the ‘‘classical’’ nuclear hormone
receptor gene regulatory pathways. In cardiac myocytes, limited
evidence shows that 17b-estradiol (E2), often at supra-physiolog-
ical concentrations, rapidly affects membrane ionic conductance,
Ca
2+ handling, and excitation-contraction coupling [12,15,16,
17,18]. The effects of BPA on the myocardium, including its rapid
action, are entirely unknown.
The aims of the present study were to investigate the rapid, sex-
specific effects of physiologically-relevant concentrations of BPA
and E2 on rodent cardiac myocytes and hearts, with a focus on the
arrhythmogenic effect of estrogens, and to determine the
underlying cellular mechanism of the rapid actions of estrogens.
Results
BPA and E2 Rapidly Promote Triggered Activities in
Female Rat Myocytes
Triggered activities are abnormal excitations of cardiac myocytes
‘‘triggered’’ by preceding impulses, and are a key arrhythmogenic
mechanism in the heart [19,20]. The effect of BPA or E2 exposure
on triggered activities, measured as spontaneous after-contractions
following repeated pacing, was assessed in isolated ventricular
myocytes from each sex (Figure 1A). In myocytes from female rat
hearts, brief exposure (2–7 min) to BPA or E2 (10
29 M) resulted in
detectable after-contractions in 21% and 18% of the myocytes,
respectively. By comparison, only 1% of myocytes displayed after-
contraction under control conditions. Exposure to a mixture of
10
29 M BPA and 10
29 M E2 significantly increased the percentage
of cells with after-contractions to 42%. Measurements of triggered
activity as spontaneous Ca
2+ transients following pacing yielded
similar results (Figure 1B). BPA or E2 alone (10
29 M) induced
spontaneous Ca
2+ transients in 27% and 23% of female rat
myocytes, respectively, and in 45% of myocytes when added as
10
29 M equal molar mixture.
In contrast to the robust effects of the BPA and E2 mixture,
increasing E2 or BPA concentration two-fold from 1610
29 Mt o
2610
29 M did not increase the induced responses in female rat
Figure 1. Acute exposures to BPA and E2 promote triggered activities in female rat ventricular myocytes. (A) Left, representative
contraction traces of female rat myocytes elicited by pacing under control and upon acute exposure to 10
29 M BPA. Arrow indicates spontaneous
after-contraction (i.e., triggered activity) following pacing. Right, percentages of myocytes with after-contractions under various conditions. N=52–87
myocytes. (B) Left, representative Ca
2+ transients in female rat myocytes elicited by pacing under control and upon acute exposure to 10
29 M BPA.
Arrows indicate spontaneous Ca
2+ after-transients (i.e., triggered activity) following pacing. Right, percentages of myocytes with after-transients
under various conditions. N=35–74 myocytes. (C) Percentages of female myocytes with triggered activities under BPA or E2 alone, at 10
29 and
2610
29 M, and under a mixture of BPA and E2, both at 10
29 M; n=42–66. (D) Percentages of male ventricular myocytes with triggered activities
under control, 10
29 M BPA and a mixture of BPA and E2, both at 10
29 M, N= 32 myocytes for all groups. #:P .0.1; *: P,0.05; **: P,0.01 vs. control
in a x
2 test. NS (not significant): P.0.1.
doi:10.1371/journal.pone.0025455.g001
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effects observed in response to an equal molar mixture of BPA and
E2 were not the simple result of an additive increase in estrogen
concentration. The pro-arrhythmic cardiac sensitivity to BPA
and/or E2 was female-specific; exposure of ventricular myocytes
from male rats to BPA alone or BPA combined with E2 did not
result in any increase in triggered activities (Figure 1D).
BPA and E2 Promote Ventricular Arrhythmias in Female
Rat Hearts
The effect of BPA and E2 on arrhythmias in rat hearts was
examined by surface electrocardiogram (Figure 2). In both female and
male rat hearts, arrhythmias were absent under control conditions and
very infrequent following exposure to 10
29 BPA and E2. In female rat
hearts under catecholamine-induced stress [isoproterenol (Iso),
10
28 M], exposure to BPA and E2 markedly increased the frequency
of ectopic ventricular beats from 5.862.2 to 2068p e r2 0 m i n
(P,0.05; Figure 2A and 2B). In addition, BPA and E2 exposure in the
presence of Iso resulted in episodes of non-sustained ventricular
tachycardia (VT) in one of the six female hearts analyzed (Figure 2A).
The arrhythmogenic effects of BPA and E2 were female-specific; in
male rat hearts, exposure to E2 and BPA did not increase the
frequency of premature ventricular beats compared with Iso alone
(Figure 2C), or induce other forms of identifiable arrhythmia.
BPA and E2 Alter Myocyte Calcium Handling
Abnormal Ca
2+ handling plays an important role in the
development of triggered activities in the heart [20,21]. The
effects of BPA and E2 on Ca
2+ handling in female rat myocytes
were examined. BPA and E2 alone, and more so when combined,
significantly increased the amplitude of field-stimulated Ca
2+
transients (Figure 3A and 3B). The average peak Ca
2+ transient
amplitude (F/F0 ratio) was 2.3 in control myocytes, and 3.5 and
3.6 in myocytes exposed to BPA or E2, respectively. An additional
increase in peak Ca
2+ transient amplitude to 4.8 was observed in
myocytes exposed to BPA and E2. The decay rate of the Ca
2+
transients was also increased (Figure 3C), indicating enhanced SR
Ca
2+ reuptake [20]. Sarcoplasmic reticulum (SR) Ca
2+ load was
assessed as the amplitude of Ca
2+ transients induced by caffeine
(an agonist of ryanodine receptors, or RyRs) (Figure 3D).
Consistent with enhanced SR Ca
2+ reuptake, BPA and E2
markedly increased SR Ca
2+ load on a beat-to-beat basis
(Figure 3D and 3E). The decay rate of the caffeine-induced
Ca
2+ transient, an indication of Ca
2+ extrusion from the cytosol,
was not affected (Figure 3F). The fraction of SR Ca
2+ release on a
beat-to-beat basis, calculated from the ratio of field-stimulated and
caffeine-induced Ca
2+ transients, was also increased following BPA
and E2 exposures (Figure 3G). However, the L-type Ca
2+ current
was not affected by BPA (Figure 3H). As a whole, these results
indicate that a key effect of estrogen exposure on myocyte Ca
2+
handling is enhanced SR Ca
2+ release and reuptake.
BPA and E2 Promote Triggered Activities by Increasing
SR Calcium Leak
The effectof BPA and E2 on SR Ca
2+ release was further assessed
by analysis of Ca
2+ sparks. Ca
2+ sparks, which represent local and
quantal release of SR Ca
2+ through clusters of RyRs [22], were
examined in quiescent myocytes (Figure 4). Acute exposure to
10
29 M BPA significantly increased the average Ca
2+ spark
frequency in female rat myocytes from 3.2 to 4.9 sparks/100 mm/s
(Figure 4A and 4B), with no change in peak amplitude (Figure 4B) or
spatial/temporal properties (data not shown). Likewise, E2 rapidly
increased Ca
2+ spark frequency without altering spark amplitude
(Figure 4C and 4D). Spark frequency is affected by both RyR open
probability and SR Ca
2+ load. Neither E2 nor BPA affected SR load
in quiescent myocytes in the absence of active Ca
2+ cycling (data not
shown). Therefore, the observed increase in Ca
2+ release is most
likely the result of increased RyR opening. The role of increased
spontaneous SR Ca
2+ release, or ‘‘Ca
2+ leak’’, in the development of
Figure 2. Acute exposures to BPA and E2 promote ventricular arrhythmias in female rat hearts. (A) Representative surface ECG traces
from female hearts under control or in the presence of BPA and E2, both at 10
29 M, and 10
28 M isoproterenol. Asterisks indicate premature
ventricular beats (PVBs). VT: ventricular tachycardia. (B) Average frequency of PVBs in female hearts under various conditions. N=6–11 hearts.
(C) Average frequency of PVBs in male hearts under various conditions. N=7–9 hearts. Error bars are SEM. *: P,0.05 vs. control in a t-test. NS (not
significant): P.0.1.
doi:10.1371/journal.pone.0025455.g002
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[23]. Blockade of RyRs with 10
27 M ryanodine did not affect field-
stimulation elicited Ca
2+ transients (Figure 4E), but suppressed
spontaneous excitations induced by either BPA alone or BPA
combined with E2 (Figure 4E and 4F).
Ablation of ERb Abolished Rapid Effects of BPA and E2
Estradiol exerts its biological effects by activation of the nuclear
hormone receptors ERa and ERb. The role of ERb in mediating
the sensitivity of female rodent myocytes to estrogens was
examined using an ERb knockout mouse model [24]. Similar to
the effects observed in female rat myocytes, BPA and E2 rapidly
promoted the development of triggered activity in female wild type
mouse myocytes; by contrast, the stimulatory effects of estrogens
on triggered activities were completely abolished in ERb
-/- female
mouse myocytes (Figure 5A and 5B).
Discussion
Endogenous estrogens are well recognized to play important
roles in the regulation and maintenance of sex-specific differences
in cardiac physiology and pathophysiology; however, little is
known about the cardiac effects of environmental estrogenic
EDCs, such as the ubiquitous BPA, and their interactions with
endogenous estrogens. In the present study, we show that
physiologically-relevant concentrations of BPA and E2 have
female-specific pro-arrhythmic effects in rodent cardiac myocytes
and whole hearts. The effects of BPA and E2 are mediated by
ERb-signaling, through rapid alteration of myocyte Ca
2+ han-
dling, particularly by increase in Ca
2+ leak from the SR. Our
animal study results, for the first time, suggest a potential
contributing role of BPA (and potentially other estrogenic EDCs)
in the development of cardiac arrhythmias in the female heart.
Figure 3. Effect of BPA and E2 on Ca
2+ handling in female rat myocytes. (A) Representative Ca
2+ transients (CaT) elicited by steady-state field
stimulation under control and in the presence of BPA. (B) and (C) Average data on CaT amplitude and decay time constant under control (Cont), 10
29
M BPA or E2, and 10
29 M BPA plus 10
29 ME 2( B +E2). N=27–42. (D) Representative Ca
2+ transients induced by 10 mM caffeine following repeated
field stimulation. Black bars indicate exposure to caffeine. (E) and (F) Average data on caffeine-induced CaT (CaTcaff) amplitude and decay time
constant (n=14–19). Treatment labels are the same as (B) and (C). (G)S RC a
2+ release fractions under various conditions. Treatment labels are the
same as (B) and (C). N=14–19. (H) Left, representative L-type Ca
2+ currents recorded under control and upon exposure to BPA. Shown are traces
elicited by voltage steps from -40 to +20 mV in 10 mV increment, from a holding potential of -50 mV. Right, average peak ICaL densities before and
after 2–7 min exposure to 10
29 M BPA. N=7. Error bars are SEM. #:P .0.1; *: P,0.05; **: P,0.01 vs. control in a one-way ANOVA or t-test.
doi:10.1371/journal.pone.0025455.g003
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detected in over 90% of the US population with mean
concentration in the low ng/mL, or low-nanomolar range [3,4].
As an indication of internal exposure, unconjugated BPA in
plasma, serum or blood was detected in most individuals in various
sampled populations, with mean concentration also in the low-
nanomolar range [2]. Initial dose-response analysis of the rapid
effects of BPA and E2 in female myocytes was performed using
myocyte contractility as an index. For each compound, the dose-
response curve had an inverted-U shape; a stimulatory effect on
contractility was observed at doses as low as 10
212 M, with
10
29 M being the most efficacious (data not shown). Therefore,
based on experimental considerations, estimated human exposure
levels, and BPA’s pharmacodynamic profile, 10
29 M was selected
for further analysis. We demonstrated here that in ventricular
myocytes from female but not male rats, exposure to 1 nM BPA or
Figure 4. Effect of BPA and E2 on SR Ca
2+ leak in female rat myocyte. (A)C a
2+ sparks recorded from a myocyte under control and upon rapid
exposure to BPA. (B) Average data on Ca
2+ spark frequency (left) and amplitude (right) under control and after exposure to 10
29 M BPA. Data are
averages of 137 sparks (Control) and 214 sparks (BPA) from 16 myocytes. (C)C a
2+ sparks recorded from a myocyte under control and upon rapid
exposure to E2. Average effects of 10
29 M E2 on spark properties are shown in (D). Data are averages of 162 sparks (Control) and 230 sparks (E2) from
16 myocytes. (E) Representative Ca
2+ transients elicited by pacing under control, 10
29 M BPA plus 10
29 M E2, and BPA plus E2 in the presence of
ryanodine. Arrows indicate spontaneous Ca
2+ after-transients following pacing. (F) Percentages of myocytes with triggered activities under various
conditions. N=23–52 myocytes. #:P .0.1; *: P,0.05; **: P,0.01 vs. control in a t-test or one-way ANOVA.
doi:10.1371/journal.pone.0025455.g004
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the percentage of myocytes with spontaneous excitations following
repeated pacing. These triggered activities are indicative of
delayed after-depolarizations, or DADs, a myocyte phenomenon
that is recognized as a key non-reentrant arrhythmogenic
mechanism [19,20,21]. Delayed after-depolarizations are gener-
ated under SR Ca
2+ overload condition and are the result of
diastolic spontaneous Ca
2+ release from the SR. Such spontaneous
SR Ca
2+ release triggers Ca
2+ extrusion by the Na
+/Ca
2+
exchanger (NCX); the activity of the electrogenic NCX generates
a depolarizing current, leading to excitation of the myocyte during
the diastole. These ectopic excitations can propagate through the
myocardium and initiate arrhythmia events [21]. Key factors in
the development of DADs include increased SR Ca
2+ load, and
abnormal SR Ca
2+ release (i.e., SR Ca
2+ leak). In particular,
aberrant RyR opening and diastolic SR leak have been shown to
be a central factor in the development of DADs and lethal
ventricular arrhythmias under disease conditions such as heart
failure [25,26]. Consistent with the mechanism of DAD
development, we found that in female rat myocytes, rapid
exposure to BPA or E2 markedly increased SR Ca
2+ reuptake,
SR load, and the fraction of SR Ca
2+ release on a beat-to-beat
basis. Further, E2 and BPA significantly increased the frequency of
spontaneous Ca
2+ sparks, likely as a result of increasing RyR open
probability. Supporting a key role of abnormal SR leak in the pro-
arrhythmic effect of BPA in female myocytes, we showed that
suppression of RyR release by ryanodine, while not affecting
normal Ca
2+ transients, abolished DADs triggered by BPA alone
or BPA combined with E2.
Unlike the robust response of female myocytes to BPA and E2,
neither compound induced arrhythmias under baseline conditions.
However, with b-adrenergic receptor stimulation, BPA combined
with E2 resulted in a marked increase in ventricular arrhythmic
events, including premature ventricular contractions and ventric-
ular tachycardia in female rat hearts. The discrepancy between the
effects of estrogens at the myocyte and whole heart levels likely
reflects the fact that only a fraction of the single myocyte-level
abnormal electrical activities may propagate and result in
arrhythmic events. How myocyte-level triggered activities lead to
whole-myocardium arrhythmias, particularly sustained arrhyth-
mias, is complex and not fully understood. Catecholamines affect
myocyte mechanics by enhancing Ca
2+ influx through the L-type
Ca
2+ channels, SR reuptake (and consequently SR Ca
2+ load), and
RyR activities [20,27]. These effects favor SR overload and
abnormal SR Ca
2+ release, and likely potentiate the pro-
arrhythmic actions of these estrogens. Our results suggest that
BPA exposure may become a particularly significant factor for
arrhythmogenesis in females under stress conditions, and possibly
target females with existing cardiac pathophysiological conditions
that provide the substrate for arrhythmogenesis.
The rapid effects of BPA on DAD development and Ca
2+
handling appeared to be amplified in the presence of E2. This
intriguing experimental effect raises the possibility that the pro-
arrhythmic effect of BPA may be more pronounced in females
with higher levels of endogenous estrogens, such as during
pregnancy. Bisphenol A has been shown to have additive or
synergistic effects with E2 or xenoestrogens in various cell types or
systems in other studies [28,29,30,31]. These results contrast with
the findings in rat cerebellum, where BPA alone mimics the rapid
effects of E2, but acts as an antagonist when combined with E2
[32]. The mechanism(s) underlying the interaction between BPA
and E2 is currently unknown. The amplified effect of BPA and E2
in myocytes cannot be mimicked by doubling the dose of BPA or
E2 (Figure 1C), suggesting that BPA elicits rapid effects via a
mechanism that more complex than can be explained by
considering E2 and BPA as equivalent rapid signaling estrogens.
Analyses of the actions of BPA and E2 in female myocytes indicate
that these effects are mediated via differential intracellular
signaling through ERa and ERb receptor (unpublished results).
The known difference in affinity and binding properties of BPA
and E2, and the differences in their signaling effects could account
for the complex actions of E2 and BPA response. The interaction
of BPA and E2-mediated effects observed here support further the
notion that estrogenic actions are diverse and tissue and sex-
specific; the endocrine disruption actions of estrogenic EDC
should be assessed in the context of endogenous estrogens and
possibly higher order mixtures of other estrogenic EDCs.
Bisphenol A elicits its biological responses through activation of
ER or ER-like receptors. Both ERa and ERb, including those
localized to the membrane, have been shown to be expressed in
cardiomyocytes from species including rat and human [13,33,34].
Our results using the ERb-/- mouse model strongly suggest that
ERb-mediated signaling plays a central role in the rapid actions of
Figure 5. Rapid effects of estrogens in female mouse myocytes are mediated by ERb signaling. (A) Representative recordings of Ca
transients elicited by repeated pacing from WT female mouse myocytes under control and in the presence of BPA plus E2 (both 10
29 M), and from
female ERb knockout (KO) myocytes in the presence of BPA plus E2. Arrow indicates spontaneous Ca transient. (B) Percentages of myocytes with
triggered activities under control, 10
29 M BPA, and BPA plus E2, both 10
29 M. N=57–86. #:P .0.1; **: P,0.01 vs. control in a x
2 test; {:P ,0.01.
P.0.1 for WT vs KO under control condition, and among the three groups (control, BPA and BPA + E2) for KO cells.
doi:10.1371/journal.pone.0025455.g005
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with this notion, we found that in female rat myocytes, the ERb
agonist DPN mimicked the rapid effects of BPA and E2, and the
ERb selective antagonist PHTPP (but not the ERa antagonist
MPP) abolished the rapid effects of estrogens; G1, an agonist of the
orphan G-protein coupled receptor GPR30, had no detectable
effect in female myocytes (data not shown). A similar key role of
ERb in mediating the rapid effects of estrogenic EDCs has been
described in cerebellar granular cells [35]. Membrane ERs have
been shown to activate kinases including protein kinase A and C
[36,37], which are known to modulate various elements involved
in myocyte Ca
2+ handling [20,27] and may play important roles in
mediating the rapid action of BPA and E2 in female rodent
myocytes.
Despite the perception that female hormones protect women
from cardiovascular disease, disease of the cardiovascular system
is the leading cause of mortality for women in the US. According
to the American Heart Associate statistics, since 1984 more
women than men have died of cardiovascular disease every year
in the US; 53% of total cardiovascular disease deaths occur in
women. There is well-recognized sexually dimorphism in
cardiovascular disease, including cardiac arrhythmias. Compared
with men, women have a lower incidence of sudden cardiac
death owning to the protective effect of estrogens on coronary
artery disease, and have lower risk of atrial fibrillation; however,
women have higher rates of long QT syndrome, sudden cardiac
death in the absence of coronary artery disease, and ventricular
arrhythmias post myocardial infarction [14,15,38,39,40]. Inci-
dence of arrhythmias increases during pregnancy, and in women
taking oral contraceptives [14,38], suggesting that female sex
hormones may contribute to arrhythmogenesis. Our study
provides the first experimental evidence suggesting that exposure
to estrogenic EDCs like BPA, and the unique sensitivity of female
hearts to estrogens, may play a role in arrhythmogenesis in the
female heart. Elucidation of the cardiac effects of endogenous
estrogen, environmental estrogenic EDCs, and their interactions
is important for assessing the unique cardiovascular benefits and/
or risks of both sexes, and may facilitate the development of
therapeutic measures that protect against the cardiac risks
associated with estrogenic EDC exposure.
Materials and Methods
Reagents
Reagents and solvents used were of the highest purity available.
All aqueous solutions were prepared using BPA-free water
(18 MV; ,6 ppb total oxidizable organics; Millipore A10 system).
Dimethyl sulfoxide (Chromasolv Plus, HPLC #99.7%; batch
no. 00451HE), bisphenol A (BPA), CAS 80-05-7, .99%, 23,965-
8; lot Cl03105ES, isoproterenol hydrochloride, CAS 5984-95-2
and BSA, CAS 9048-46-8, .98% (batch no. 078K0730) were
from Sigma-Aldrich (St. Louis, MO). 1,3,5 (10)-estratriene-3,17b-
diol (17b-estradiol, 17b-E2; E0959, batch B0356) was from
Steraloids (Newport RI). Other chemicals were from Sigma-
Aldrich unless otherwise stated.
Animals
All animal procedures were done in accordance with protocols
approved by the University of Cincinnati Institutional Animal
Care and Use Committee and followed recommendations of the
Panel on Euthanasia of the American Veterinary Medical
Association.
Adult Sprague-Dawley rats (200–250 grams; Harlan; Indianap-
olis, IN) and ERb (Esr2) knockout mice (ERb
-/-; Jackson
Laboratory; Bar Harbor, ME) were utilized as non-surviving
sources of ventricular tissue and hearts. Animals were anesthetized
with sodium pentobarbital (80 mg/kg, i.p.) and heart rapidly
dissected for myocyte dissociation. The ERb
-/- mice and age
matched wild type littermates were reared at the University of
Cincinnati laboratory animal facility and used at 6–8 weeks of age.
This ensured that the hearts were free of abnormality associated
with systemic effects of ERb ablation that set in much later, at 5
months of age [41].
Animals were maintained on a 14 h light, 10 h dark light cycle
in standard polycarbonate caging with Sani-chip bedding
(Irradiated Aspen Sani-chip; P.J. Murphy Forest Products Corp.
Montville, NJ) to eliminate possible corn-based mycoestrogen
exposure. All animals are fed ad libitum Teklad diet 2020 (Harlan
Laboratories Inc.) which lacks soybean meal, alfalfa or animal
products that might complicate the study by introduction of
uncontrolled levels of estrogenic compounds. Sterile drinking
water was generated by a dedicated water purification system
(Millipore Rios 16 with ELIX UV/Progard 2) that reduces
oxidizable organics to less than 1% of source levels. Drinking
water was dispensed from glass water bottles. Concentrations of
BPA in drinking water and all experimental reagents were
confirmed below the level of detection of a BPA-specific and
extremely sensitive ELISA based assay with a minimum
quantitative detection limit of 0.05 ng/ml [1].
Isolation and culturing of ventricular myocytes
Ventricular myocytes from rodent hearts were enzymatically
dissociated using Langendorff perfusion with a Tyrode solution
composed of (mM) NaCl 118, KCl 5.4, HEPES 10, NaH2PO4
0.33, MgCl2 2, glucose 10 (pH=7.4) and containing 0.7 mg/ml or
1 mg/ml type II collagenase (Worthington Biochem, Lakewood,
NJ) for rat and mouse hearts, respectively. For rat myocyte
dissociation, the solution also contained 1 mg/ml BSA, 0.2 mg/ml
hyaluronidase, and 0.025 mM CaCl2. Isolated ventricular myo-
cytes were suspended in 1.0 mM Ca
2+-Tyrode solution and
allowed to sediment by gravity. Supernatant was then removed
and myocytes were resuspended. This process was repeated 2–3
times to enrich rod-shaped live myocytes and remove dead cells
and non-myocytes. Isolated rat myocytes were suspended in a
Medium-199 based solution (Gibco, catalog no. 31100-035, with
Earle’s salts and L-glutamine, without NaHCO3, lot no. 561846;
prepared using BPA-free water), plated on laminin (Sigma-
Aldrich, CAS 114956-81-9, various lots)-coated glass coverslips
at a density of approximately 5610
4 cells/cm
2 in 35610 mm
polystyrene culture dishes, and allowed to adhere for 10 minutes at
37uC. Dead myocytes did not adhere to the cover slips and were
rinsed off with additional medium. Myocytes were cultured in
2 ml medium/dish in 5% CO2 at 37uC in a humidified incubator
for 24 hours prior to analysis. Resulting cultures typically
contained .95% myocytes.
Myocyte calcium transient and spark analysis
Isolated ventricular myocytes were loaded with fluo-4 acetox-
ymethyl ester (5 mM; Molecular Probes, Eugene, OR) for 15 min
at room temperature, and then washed with Tyrode’s solution.
Myocytes were placed in Tyrode solution (with 1.8 mM CaCl2)
containing either vehicle or treatment drug, in a custom made
glass-plexiglass recording chamber at room temperature (24uC).
Analysis of Ca
2+ transients and sparks was made between 2 to 7
minutes following treatment. Ca
2+ sparks were recorded from
quiescent, unstimulated myocytes. For Ca
2+ after-transient
recording, myocytes were paced with field stimulation (Grass
S48 stimulator, Grass Instruments, Quincy, MA) for 8 seconds at a
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spontaneous Ca
2+ after-transients following pacing was recorded.
Fluorescence images were recorded using a Zeiss LSM 510
inverted confocal microscope through a 40x water-immersion
objective lens with excitation wavelength of 488 nm. Fluorescence
signals were measured at .515 nm with line-scan imaging at
3.07 ms intervals, with each line comprising 512 pixels spaced at
0.056 mm. Image processing and data analysis were performed
using IDL software (ITT Visual Information Solutions, Boulder,
CO). For analysis of the amplitude and kinetics of field-stimulated
or caffeine-induced Ca
2+ transients, fluorescence signals were
measured from fluo-4 loaded myocytes using a Nikon TE 2000
microscope and an InCyt Standard PM photometry system
(Intracellular Imaging, Cincinnati, OH). Field stimulated Ca
2+
transients were elicited with 2 ms 1.5x threshold pulses at a rate of
0.5 Hz. For recording of caffeine-induced Ca
2+ transients,
myocytes were field stimulated at 0.5 Hz for 20 seconds, and
were exposed to solution containing 10 mM caffeine immediately
following cessation of pacing.
Surface electrocardiography (ECG) from rat hearts
Following dissection, hearts were quickly cannulated via the
aorta, and retrograde perfused on a Langendorff apparatus with
37uC Krebs-Henseleit solution containing (mM) NaCl 118, KCl
4.7, MgSO4 1.2, KH2PO4 1.2, EDTA 0.5, CaCl2 2.5, NaHCO3
25, and glucose 11, pH=7.4, bubbled with 95% O2 and 5% CO2,
at a pressure of 80 mmHg and perfusion rate of ,15 ml/min.
Hearts were perfused under control conditions for at least 1 hour
to allow stabilization before exposure to solution containing
treatment drug(s). Electrocardiograph was continuously measured
from the surface of the heart, with electrodes positioned at the base
and apex of the heart. Data collection and analysis were
performed using the Powlab 4/30 data acquisition system and
LabChart 7 software (AD Instruments, Colorado Springs, CO).
Myocyte after-contraction analysis
Myocytes were placed in a plexiglass cell chamber filled with
1.8 mM CaCl2-Tyrode solution at room temperature (24uC). The
solution also contained either vehicle or various treatment drugs.
Myocyte contraction was recorded between 2 to 7 minutes
following treatment. Myocytes were excited with field stimulation
(Grass S48 stimulator, Grass Instruments, Quincy, MA) with 2 ms
1.5x threshold pulses at a rate of 0.5 Hz. Steady state myocyte
shortening was imaged with a CCD camera and examined using a
video-edge detector (Crescent Electronics, Sandy, UT). Data were
sampled through an Axon Digidata 1322A board using the
PCLAMP 9 software (both from Molecular Devices, Sunnyvale,
CA).
Patch clamp recording of the L-type Ca
2+ current
The L-type Ca
2+ current was recorded at room temperature
(24uC) using the whole-cell patch clamp technique with an
Axonpatch-200B amplifier (Axon Instruments, Foster City, CA).
Extracellular solution contained (in mM) TEA-Cl 137, CsCl 5.4,
CaCl2 2, MgCl2 1, HEPES 5, glucose 10, and 4-aminopyridine 3
(pH=7.4). Glass pipettes were filled with solution containing (in
mM) Cs-aspartate 115, CsCl 20, EGTA 11, HEPES 10, MgCl2
2.5, Mg-ATP 2 and Na-GTP 0.1 (pH=7.2), and had a resistance
of 1.5–2.5 MV. After the membrane was ruptured, cells were
clamped at –50 mV for 5 minutes to allow dialysis of the
intracellular solution and stabilization of the Ca
2+ currents before
measurement began. Data collection and analysis were performed
using PCLAMP 9 software.
Statistical analysis
All experiments were independently repeated using myocytes
isolated from at least 4 hearts. Statistical analysis was conducted
using a paired or unpaired t-test, or one-way or 2- way (e.g. sex vs.
treatment) analysis of variance (ANOVA) with differences between
treatment groups assessed using a multiple comparison post-test.
Frequency of events (e.g., percentage of myocyte with triggered
activities) was analyzed using a chi-square (x
2) test. Minimal level
of statistical significance for differences in values is considered to
be p,0.05 (*). Data was analyzed with SigmaPlot 11.0, Excel and
GraphPad PrismH version 5.0.
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